While some say safety parameters are good, others have asked for efficacy data

Is it ethical to offer one healthcare worker the Covaxin whose efficacy is unknown and another healthcare worker the Covishield whose efficacy is known even..

Bharat Biotech’s Chairman and Managing Director Dr Krishna Ella interacted exclusively with Zee News.

Along with 3.64 lakh doses of Covishield, manufactured by Serum Institute of India, the Telangana Health department has received 20,000 doses of Bhara

While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin,..

Government has placed purchase order for 55 lakh doses

Government has placed purchase order for 55 lakh doses

Vaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown..

Health Minister C. Vijayabaskar emphasised that both the vaccines -- Covishield from SII and Covaxin from Bharat Biotech -- have been tested and approved of..

On Tuesday, the first consignment of COVID-19 vaccine 'Covishield' had arrived at Delhi's IGIA from Pune

On Tuesday, the first consignment of COVID-19 vaccine 'Covishield' had arrived at Delhi's IGIA from Pune

Both Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.

Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not..

A failure to investigate the conduct of the recent Covaxin phase-3 trial can affect the course of other studies under way

‘Twelve million doses to be shipped’

Vaccine rollout starts on January 16.

Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects..

Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous..

Health Secretary J. Radhakrishnan said the State was allotted 5,56,500 doses of COVID-19 vaccines -- 5,36,500 doses of Covishield vaccine and 20,000 doses of..

Bengal CM Mamata Banerjee on Monday asked whether “adequate scientific confirmation was available in support of” the vaccines Covishield and Covaxin, which..

India's drugs regulator has approved Oxford vaccine Covishield, being manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech..

Organisations working with Bhopal gas disaster victims on Sunday urged PM Modi to stop the clinical trial of Covaxin in Bhopal, alleging irregularities in..

The groups working for the Bhopal gas tragedy survivors said consent procedure and other protocols were being flouted.

A six-member investigation team of the state-run Gandhi Medical College (GMC) in Bhopal on Saturday night said People’s Medical College had followed ICMR..

Bharat Biotech has said that the probable cause of death of a 42-year-old volunteer was cardio respiratory failure as a result of suspected poisoning.

The 42-year-old man died on December 21, 10 days after he participated in the clinical trial for Covaxin held at a private hospital in Bhopal.

Virologist Shahid Jameel says there is no experimental evidence so far that Covaxin will neutralize newly emerging mutants any better

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said..

Covishield and Covaxin, the two vaccines accorded emergency use approval, are on the verge of being available in the country, health minister Harsh Vardhan said..

He is the first foreign envoy to be part of Phase 3 COVID-19 vaccine trials in India.

Union Health Minister Harsh Vardhan on Thursday said that the COVID-19 vaccines  'Covishield' and 'Covaxin' are on the verge of being available in the country.

While FAQs of the Ministry of Health and Family Welfare (MOHFW) are silent on the issue of citizens' choice when it comes to being inoculated, ahead of a mass..

With the Drugs Controller General of India granting emergency-use approval to two vaccines on January 3, the debate among medical professionals now is which one..

In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and..